Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) hit a new 52-week high during trading on Thursday. The stock traded as high as $103.22 and last traded at $102.82, with a volume of 3,115 shares traded. The stock had previously closed at $96.00.
Wall Street Analysts Forecast Growth
Separately, Erste Group Bank upgraded Sandoz Group to a “strong-buy” rating in a report on Thursday, August 27th. Four investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Strong Buy”.
Check Out Our Latest Research Report on SDZNY
Sandoz Group Trading Down 1.3%
The business’s fifty day moving average price is $87.71 and its 200 day moving average price is $84.10.
About Sandoz Group
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.
Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.
See Also
- Five stocks we like better than Sandoz Group
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
